Diffuse large B cell lymphoma is the most common type of non-Hodgkin's lymphoma, representing approximately one-third of all cases and involving the gastrointestinal tract in about 18%. With the development of modern chemotherapeutic regimens and advances in medical care, the prognosis for malignant lymphoma can be excellent. However, because of the aggressive adjuvant therapy required, complications such as bowel perforation may be fatal. In cases of chemotherapy for malignant lymphoma, we should keep in mind the possibility of perforation of the bowel after chemotherapy. Early detection is important to save patients. 
INTRODUCTION
In diffuse large B cell lymphoma, combination chemotherapy is the initial treatment and CHOP is the treatment of choice.(1) Using this approach, 60 to 70% of patients are expected to achieve complete remission, 50 to 70% of complete responders will be cured, and the 5-year survival is 46%. We report our experience of three cases of bowel perforation, in which no lymphoma cells were found, after chemotherapy for diffuse large B cell lymphoma.
CASE REPORTS Case 1
A 29-year-old female was hospitalized via our emergency room with diffuse abdominal tenderness. She was diagnosed, via histology, with diffuse large B cell lymphoma of the tonsil ( (Fig. 2A) .
We carried out emergency surgery that day. We found a perforation of the small bowel with no recurrent mass. 
Case 2
The second patient was a 61-year-old male who visited the emergency room because of right lower quadrant pain.
He had been diagnosed with terminal ileal lymphoma (diffuse large B cell lymphoma) ( Abdominal computed tomography showed high amounts of free air in the peritoneal cavity (Fig. 2B ).
We performed emergency surgery and found a perforation in the colon in the distal portion of the previous anastomotic site. Segmental resection of the perforation site and anastomosis was performed.
The bowel mucosa showed ischemic changes, submucosal edema, hemorrhage, and serosal inflammation with no lymphoma cells in the histology (Fig. 3B) . Commonly, gastrointestinal perforation occurs at sites involving lymphoma cells. Nevertheless, the bowel can also be perforated during chemotherapy or corticosteroid therapy with no lymphoma cell invasion, as in our cases. an irregular surface, intense inflammatory cell infiltration, and perforation (A). The bowel showed mucosal ischemic changes and submucosal edema, with hemorrhage and serosal inflammation (B). The specimen contained many foamy macrophages and multinucleated giant cells in the submucosa and muscle proper, with serosal reaction and a focal segment of mucosal ulceration (C)(H&E, ×20).
